Early Complications Following Articular Calcaneus Fracture Repair

• Main Authors: Derrick M. Knapik, MD, Michael J. Hermelin, MD, Joseph E. Tanenbaum, BA, Heather A. Vallier, MD
• Format: Article
• Language: English
• Published: Wolters Kluwer 2019-12-01
• Series: OTA International
• Online Access: http://journals.lww.com/10.1097/OI9.0000000000000049

Abstract. Objectives:. To assess complications and secondary operations in patients treated with either open reduction and internal fixation (ORIF) versus percutaneous fixation of displaced intra-articular calcaneus fractures. Design:. Retrospective comparative study. Setting:. Level 1 trauma center. Patients/Participants:. Ninety-three adult patients with 111 fractures treated by a single orthopaedic traumatologist between 2001 and 2014. Intervention:. ORIF through an extensile lateral approach or percutaneous reduction and internal fixation. Main Outcome Measurements:. Wound-healing complications, infections, posttraumatic arthrosis (PTOA), and secondary procedures. Results:. Fifty patients with 58 fractures underwent ORIF, and 43 patients with 53 fractures had percutaneous fixation. Mean age was 43 years, and 80% were male. Open fractures and two-part fractures were more often treated percutaneously (26% vs 8%, P = 0.03) and (49% vs 31%, P = 0.02), respectively. Patients undergoing percutaneous fixation were more often tobacco users (58% vs 36%, P = 0.04) and with history of alcohol and other substance abuse. Twenty-seven patients (29%) had 28 complications, including 21% with PTOA, with no differences based on type of treatment. Six patients had secondary procedures, with no difference based on type of treatment. Patients with open fractures (P = 0.001) or tobacco abuse (P = 0.005) were more likely to experience complications. Conclusions:. No differences in complication rates were found for ORIF versus percutaneous fixation. Regardless of fixation technique, patients with open fractures or history of tobacco abuse were more likely to develop complications. Percutaneous reduction and fixation represents an alternative to extensile ORIF in terms of similar early and late complications, particularly in high risk patients. Level of Evidence:. Therapeutic Level III